Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Early Stage Venture
Geographical Focus
United States
Industries Focus
- Healthcare
- Life Sciences
- Information Technology
Investor Details Founded: 1999
iNetworks is a venture capital firm that accelerates solutions by providing capital and intellectual resources to solve critical problems, primarily focusing on healthcare and life sciences businesses developing breakthrough technologies to improve clinical outcomes and save resources for healthcare providers. Founded in 1999, iNetworks has consistently ranked among the top quartile performers in the private equity industry over the past decade. The firm partners with visionary entrepreneurs to unlock potential, drive innovation, and shape the future.
The firm's investment strategy emphasizes operational excellence, strategic mergers and acquisitions, organic growth, governance, and building robust ecosystems. iNetworks works closely with management teams to optimize processes, enhance efficiency, and implement best practices. They leverage their extensive network and deal expertise to identify and execute strategic acquisitions that expand market reach, strengthen competitive advantages, and create synergies within the portfolio. Additionally, iNetworks nurtures internal growth engines within their portfolio companies through strategic initiatives, including new product launches and market expansion.
iNetworks is committed to building resilient businesses equipped for long-term success, with a strong emphasis on ESG principles and positive social and environmental impact. Their objective is to generate exceptional returns for investors while making a lasting impact on the world. The firm meticulously cultivates opportunities in future-shaping sectors like healthcare breakthroughs, resilient infrastructure, and transformative technologies, ensuring that financial prosperity and positive impact go hand in hand.
Requirements
- Focus on healthcare and life sciences businesses developing breakthrough technologies
- Emphasis on improving clinical outcomes and saving resources for healthcare providers
- Commitment to operational excellence and strategic growth initiatives
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Wenzel Spine
- PennAlt Organics
Mentioned In
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$299.00
Claim this Investor
Are you an official representative of iNetworks?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim